JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Scope & Guideline

Fostering knowledge in pharmacology for real-world impact.

Introduction

Explore the comprehensive scope of JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0269-4727
PublisherWILEY-HINDAWI
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1976 to 2024
AbbreviationJ CLIN PHARM THER / J. Clin. Pharm. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON WIT 5HE, ENGLAND

Aims and Scopes

The Journal of Clinical Pharmacy and Therapeutics focuses on the intersection of clinical pharmacy practice and therapeutic outcomes, emphasizing research that enhances patient care through effective medication management. The journal covers a broad spectrum of topics related to pharmacotherapy, drug safety, and the role of clinical pharmacists in optimizing therapeutic strategies.
  1. Clinical Pharmacotherapy Research:
    The journal publishes studies that investigate the efficacy, safety, and pharmacokinetics of various medications used in clinical settings, highlighting how these factors impact patient outcomes.
  2. Pharmacovigilance and Drug Safety:
    Research on adverse drug reactions, drug interactions, and the overall safety of medications is a core focus, as the journal aims to improve the understanding of drug-related risks.
  3. Pharmacogenomics and Personalized Medicine:
    The publication includes studies that explore the role of genetic variations in drug response, contributing to personalized treatment strategies tailored to individual patient needs.
  4. Pharmaceutical Care Models:
    The journal emphasizes innovative pharmaceutical care models that enhance patient engagement and improve medication adherence, particularly in chronic disease management.
  5. Clinical Guidelines and Evidence-Based Practice:
    Articles that assess the quality and applicability of clinical guidelines in pharmacotherapy are featured, promoting evidence-based practices among clinicians.
  6. Interdisciplinary Collaboration in Healthcare:
    The journal highlights the importance of collaboration between pharmacists and other healthcare professionals to optimize therapeutic outcomes and ensure comprehensive patient care.
The Journal of Clinical Pharmacy and Therapeutics has witnessed emerging themes that reflect the evolving landscape of clinical pharmacy and therapeutics. This section highlights these trending topics, indicating where research focus is intensifying.
  1. Telepharmacy and Remote Patient Monitoring:
    With the rise of telehealth, research on telepharmacy practices and their impact on medication management and patient outcomes has gained momentum, especially during and after the COVID-19 pandemic.
  2. Integrated Care Models for Chronic Disease Management:
    There is an increasing emphasis on integrated care models that involve collaboration among healthcare providers to manage chronic diseases effectively, highlighting the pharmacist's role in patient-centered care.
  3. Pharmacogenomics and Precision Medicine:
    Research focusing on pharmacogenomics is on the rise, reflecting the shift towards personalized medicine, where treatment is tailored based on individual genetic profiles to optimize therapeutic outcomes.
  4. Antimicrobial Stewardship Programs:
    The growing concern over antibiotic resistance has led to an uptick in publications related to antimicrobial stewardship, emphasizing strategies for optimizing antibiotic use in various healthcare settings.
  5. Real-World Evidence and Outcomes Research:
    There is a notable trend towards utilizing real-world evidence to assess the effectiveness and safety of medications in diverse populations, moving beyond controlled clinical trial settings.

Declining or Waning

While the Journal of Clinical Pharmacy and Therapeutics continues to thrive in many research areas, certain themes have shown a decline in publication frequency over recent years. This section identifies those waning topics, reflecting shifting priorities within the field.
  1. Traditional Drug Formulations and Delivery Systems:
    Research focusing on conventional drug formulations has decreased, as there is a growing interest in novel delivery systems and formulations that enhance bioavailability and therapeutic efficacy.
  2. General Drug Utilization Studies:
    While drug utilization studies remain relevant, the focus has shifted towards more specific analyses that include pharmacogenomics and personalized approaches, leading to a decline in broader utilization studies.
  3. Basic Pharmacology and Mechanism of Action Studies:
    There has been a noticeable reduction in the publication of basic pharmacological studies without direct clinical implications, as the journal's focus has moved towards translational research that informs clinical practice.
  4. Case Reports on Rare Adverse Events:
    Although case reports are valuable, there has been a decrease in publications concerning rare adverse events, possibly due to a preference for studies that provide broader insights into common clinical issues.

Similar Journals

JOURNAL OF PHARMACY PRACTICE

Exploring the forefront of pharmaceutical sciences.
Publisher: SAGE PUBLICATIONS INCISSN: 0897-1900Frequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

Journal of Pharmaceutical Health Care and Sciences

Advancing pharmaceutical innovations for a healthier tomorrow.
Publisher: BMCISSN: 2055-0294Frequency: 1 issue/year

The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.

International Journal of Clinical Pharmacy

Bridging Research and Practice in the World of Pharmacy
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

ANNALS OF PHARMACOTHERAPY

Empowering the Next Generation of Pharmacotherapy
Publisher: SAGE PUBLICATIONS INCISSN: 1060-0280Frequency: 12 issues/year

ANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.

Journal of the American College of Clinical Pharmacy

Empowering professionals through cutting-edge research.
Publisher: WILEYISSN: Frequency: 6 issues/year

Welcome to the Journal of the American College of Clinical Pharmacy, a distinguished publication in the field of pharmacy and related health professions, published by WILEY since 2018. With a strong commitment to advancing clinical pharmacy practices, this journal serves as a vital resource for researchers, professionals, and students seeking to stay at the forefront of pharmaceutical science. Boasting impressive category quartiles, including Q2 in Pharmaceutical Science and Pharmacy, alongside a notable Scopus ranking in Health Professions and Pharmacology, it stands as a key platform for disseminating cutting-edge research and innovative approaches in clinical pharmacy. Although this journal maintains a subscription-based model, its rigorous peer review process and emphasis on high-quality research ensure that it continues to make significant contributions to the field. Join us in exploring the latest insights and developments from a community dedicated to improving patient care and health outcomes.

Australian Prescriber

Bridging Research and Clinical Practice.
Publisher: Therapeutic Guidelines LtdISSN: 0312-8008Frequency: 6 issues/year

Australian Prescriber is a distinguished open-access journal published by Therapeutic Guidelines Ltd, aiming to advance the field of pharmacology and medical prescriptions. Since its inception in 1994, this journal has been dedicated to disseminating essential findings and insights related to therapeutic guidelines and pharmaceutical care, making it an invaluable resource for healthcare professionals and researchers alike. With an ISSN of 0312-8008 and an E-ISSN of 1839-3942, it caters to an audience that values evidence-based medicine, empowering practitioners with knowledge to enhance clinical practice. The journal currently holds a Q2 ranking in the Pharmacology (medical) category and is recognized in the 51st percentile among its peers, reflecting its significant contributions to the medical field. Available from 1995 to 2024, this journal not only serves as an academic platform but also a critical discussion forum for professionals keen on improving pharmacological practices in Australia and beyond.

PHARMAZIE

Pioneering insights in toxicology and pharmaceutics.
Publisher: AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBHISSN: 0031-7144Frequency: 12 issues/year

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Unlocking the future of drug development and innovation.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

European Journal of Hospital Pharmacy

Navigating the Future of Pharmacy in Hospital Settings
Publisher: BMJ PUBLISHING GROUPISSN: 2047-9956Frequency: 6 issues/year

The European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.

HOSPITAL PHARMACY

Transforming pharmaceutical sciences for the future of health.
Publisher: SAGE PUBLICATIONS INCISSN: 0018-5787Frequency: 6 issues/year

Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.